Preclinical evidence for GABAB agonists as a pharmacotherapy for cocaine addiction

This publication has 15 references indexed in Scilit:

• Randomized Placebo-Controlled Trial of Baclofen for Cocaine Dependence
  The Journal of Clinical Psychiatry, 2003
• The effects of ventral tegmental administration of GABAA, GABAB, NMDA and AMPA receptor agonists on ventral pallidum self-stimulation
  Behavioural Brain Research, 2002
• The GABA B antagonist CGP56433A attenuates the effect of baclofen on cocaine but not heroin self-administration in the rat
  Psychopharmacology, 2002
• Intra-VTA Baclofen Attenuates Cocaine Self-Administration on a Progressive Ratio Schedule of Reinforcement
  Pharmacology Biochemistry and Behavior, 2000
• Response of nicotine self-administration in the rat to manipulations of mu-opioid and γ-aminobutyric acid receptors in the ventral tegmental area
  Psychopharmacology, 2000
• The GABAB agonist CGP 44532 decreases cocaine self-administration in rats: demonstration using a progressive ratio and a discrete trials procedure
  Neuropharmacology, 1999
• Activation of ventral tegmental GABAB receptors inhibits morphine-induced place preference in rats
  European Journal of Pharmacology, 1996
• Baclofen Attenuates the Reinforcing Effects of Cocaine in Rats
  Neuropsychopharmacology, 1996
• The effects of ventral tegmental administration of GABAA, GABAB and NMDA receptor agonists on medial forebrain bundle self-stimulation
  Behavioural Brain Research, 1995
• The effects of dose and access restrictions on the periodicity of cocaine self-administration in the rat
  Drug and Alcohol Dependence, 1993